The biggest index of biotech stocks turned red for the year, and it had nothing to do with clinical trials, drug revenues, or pharmaceutical mergers. trib.al/tFLWGKg

you will enjoy this story or I will literally eat this tweet statnews.com/2016/05/11/was…

This week on 'The Readout LOUD' podcast: How would you spend $13 billion in cash? Is biotech stale? And remember Dendreon? trib.al/MLc6gZm

A VERY special episode of the Readout LOUD with a SHOCKING ending...

Listen: Vertex’s big deal, biotech’s red numbers, & an industry history lesson statnews.com/2024/04/11/rea… via STAT

New STAT exclusive: The Alzheimer’s treatment Leqembi could cost the entire Medicare program $3.5 billion in 2025, according to a document obtained by Bob Herman and Rachel Cohrs Zhang. trib.al/3aZdRnm

Join Helen Branswell 🇨🇦 and Andrew Joseph for a conversation on infectious diseases on STAT+ Connect at 2:30 PM ET today: trib.al/OwCyEup

A study of children with cancer shows that testing tumor cells against hundreds of drugs, called functional precision medicine, can have great benefit. Read here: trib.al/49iNqUQ

The DOJ is accusing Regeneron Pharmaceuticals of manipulating Medicare pricing by inflating the average sales price for its Eylea treatment for serious eye disease. trib.al/D92u7zY

Bernie Sanders is pushing for $10 billion in mandatory funding over the next decade to establish a new #LongCovid research program at the NIH. trib.al/XlAVywg

Medicare estimates a new Alzheimer’s drug could cost the program billions of dollars by next year — well beyond what Wall Street or the drug’s manufacturer project. trib.al/esK8UJE

The country's biggest #hospital chain, HCA, told CMS it spent ~$1 billion more on charity care than it reported to shareholders, helping it draw more taxpayer $ from safety-net programs

“This is the underbelly of the health care system.'

shorturl.at/pqrFW via STAT

The world needs answers about long #Covid , and treatment options for the people suffering from it. Sen. Bernie Sanders has a plan. STAT's Isa Cueto reports. statnews.com/2024/04/11/san…

Medicare expects to spend $3.5 billion on the Alzheimer's treatment Leqembi in 2025 — well beyond what Wall Street or even the drug's manufacturer has projected. Read more from Rachel Cohrs Zhang and me: statnews.com/2024/04/11/med…

Our #STATOpenDoors community event is tonight in Boston! Join us for a conversation on how GLP-1 drugs are transforming health care markets: trib.al/zoTfdAZ

The European Parliament voted to adopt legislation that is supposed to transform the way medicines are brought to market and accessed across much of Europe. trib.al/jgCiRoA

When a cancer drug fails, oncologists often fly blind. A precision technique might light the way statnews.com/2024/04/11/ped…

This is weird.

Medicare estimates $3.5 billion cost on Alzheimer's drug Leqembi. Which is several times what Wall Street and the company expect.

By ⁦Bob Herman⁩ and ⁦Rachel Cohrs Zhang⁩.

(Personally I would bet on a lower number here…) statnews.com/2024/04/11/med…

Medicare estimates that a new Alzheimer’s treatment could cost the program billions of dollars by next year — well beyond what Wall Street projects. trib.al/Ytv5ecv

Studies show patients who use a direct-to-consumer telehealth visit are more likely to receive an antibiotic. CDC renews guidelines to prevent overuse. trib.al/BRrE0bd

There are hundreds of cancer drugs. A new study suggests that personalized lab tests can help guide doctors to the right one. trib.al/8dVlYRt